Drug recall D-0434-2023
Product
Heparin Sodium, 25,000USP units per 250 mL, (100 USP units per mL) in 5% Dextrose Injection, 250 mL Excel Container, B.Braun Medical Inc, Bethlehem, PA. 18018-3524 USA. NDC 0264-9587-20.
Reason for recall
Subpotent Drug: low Anti-Factor IIa potency.
Lots and codes
Lot J2C017; Expiration: 9/30/2023.
Recall details
- Recalling firm
- B. Braun Medical Inc, Irvine, CA
- Quantity
- 30672
- Distribution
- Nationwide in the USA
- Recall initiated
- March 1, 2023
- Terminated
- March 13, 2024
Related products
- Heparin Sodium in Dextrose – drug information
- NDC 0264-9587 Heparin Sodium in Dextrose · Heparin Sodium 10000 [USP'U]/100mL; Dextrose Monohydrate 5… · B. Braun Medical Inc.
- NDC 0264-9577 Heparin Sodium in Dextrose · Heparin Sodium 5000 [USP'U]/100mL; Dextrose Monohydrate 5… · B. Braun Medical Inc.
- NDC 0264-9567 Heparin Sodium in Dextrose · Heparin Sodium 4000 [USP'U]/100mL; Dextrose Monohydrate 5… · B. Braun Medical Inc.